IL17A and cancer: The role of the IL-23/IL-17 axis has been demonstrated in other systemic diseases such as rheumatoid arthritis [71], cancer [72], psoriasis [73], kidney disease [74], inflammatory bowel disease [75] and cardiovascular diseases [76].